“…3,4 Resistant bacteria caused more severe clinical diseases for longer period of time which causes abundant economic losses. [1][2][3][4] Documented data revealed that pathogenic bacteria and especially Staphylococcus aureus (S. aureus), Escherichia coli (E. coli), Bacillus cereus (B. cereus), Pseudomonas aeruginosa (P. aeruginosa), Listeria monocytogenes (L. monocytogenes), Klebsiella pneumoniae (K. pneumoniae) and Salmonella typhi (S. typhi) exhibited the high levels of resistance against aminoglycosides, tetracyclines, lincosamides, macrolides, beta-lactams, quinolones, fluoroquinolone and cephems groups of antibiotics. [1][2][3][4][5][6][7][8] Therefore, therapeutic and pharmacological factories tried to use from novel sources for antimicrobial agents to produce strong antibiotic drugs.…”